ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts ...

The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

Fiduciary Management Inc. (FMI), an independent money management firm, released its “FMI International Equity Strategy ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME Magazine’s 2024 ...

DUBLIN, January 07, 2025 -- ( BUSINESS WIRE )-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical ...

Quoin Pharmaceuticals (QNRX) announces interim clinical data from its ongoing Investigator Pediatric Netherton Syndrome clinical study. The ...

GeoVax Labs (GOVX) announced significant progress in advancing Gedeptin as a cancer therapy. Gedeptin, based on a Gene-Directed Enzyme Prodrug ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME Magazine’s 2024 list of ...

ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals ...

At Mayo Clinic, the needs of the patient come first. Part of this commitment involves conducting medical research with the goal of helping patients live longer, healthier lives. Through clinical ...

Royal Bank of Canada reissued their outperform rating on shares of ICON Public (NASDAQ:ICLR – Free Report) in a research report report published on Wednesday morning,Benzinga reports. Royal Bank of ...